skip to main content
Idioma:
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Liposomal Cytarabine (DepoCyte) for Treatment of Myeloid CNS Relapse in CML Occurring during Therapy with Imatinib
Liposomal Cytarabine (DepoCyte) for Treatment of Myeloid CNS Relapse in CML Occurring during Therapy with Imatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liposomal Cytarabine (DepoCyte) for Treatment of Myeloid CNS Relapse in CML Occurring during Therapy with Imatinib

Aichberger, Karl J. ; Herndlhofer, Susanne ; Agis, Hermine ; Sperr, Wolfgang R. ; Rabitsch, Werner ; Esterbauer, Harald ; Knoebl, Paul ; Sillaber, Christian ; Jaeger, Ulrich ; Valent, Peter

Blood, 2007-11, Vol.110 (11), p.4556-4556 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

Andreadis, Charalambos ; Tam, Constantine S. ; Borchmann, Peter ; Jaeger, Ulrich ; McGuirk, Joseph P. ; Holte, Harald ; Waller, Edmund K. ; Jaglowski, Samantha ; Bishop, Michael R. ; Foley, Stephen Ronan ; Westin, Jason R. ; Fleury, Isabelle ; Ho, P Joy ; Mielke, Stephan ; Teshima, Takanori ; Salles, Gilles A. ; Schuster, Stephen J ; Bachanova, Veronika ; Maziarz, Richard T. ; Van Besien, Koen ; Izutsu, Koji ; Magenau, John M. ; Wagner-Johnston, Nina D. ; Kato, Koji ; Corradini, Paolo ; Tiwari, Ranjan ; Awasthi, Rakesh ; Lawniczek, Tomasz ; Eldjerou, Lamis K. ; Kersten, Marie Jose

Blood, 2019-11, Vol.134 (Supplement_1), p.2883-2883 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients
Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients

Awasthi, Rakesh ; Mueller, Karen Thudium ; Yanik, Gregory A. ; Tam, Constantine S. ; Rives, Susana ; McGuirk, Joseph P. ; Pulsipher, Michael A. ; Boyer, Michael W. ; Jaeger, Ulrich ; Baruchel, Andre ; Myers, Gary Douglas ; Balke-Want, Hyatt ; Schuster, Stephen J. ; Stefanski, Heather ; Bishop, Michael R. ; Waldron, Edward R. ; Anak, Özlem ; Chakraborty, Abhijit ; Bleickardt, Eric ; Wong, Stephane ; Bubuteishvili Pacaud, Lida ; Waller, Edmund K. ; Maude, Shannon L.

Blood, 2018-11, Vol.132 (Supplement 1), p.899-899 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)
Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)

Bachanova, Veronika ; Tam, Constantine S. ; Borchmann, Peter ; Jaeger, Ulrich ; McGuirk, Joseph P. ; Holte, Harald ; Waller, Edmund K. ; Jaglowski, Samantha ; Bishop, Michael R. ; Andreadis, Charalambos ; Foley, Stephen Ronan ; Westin, Jason R. ; Fleury, Isabelle ; Ho, P Joy ; Mielke, Stephan ; Teshima, Takanori ; Salles, Gilles ; Schuster, Stephen J ; Maziarz, Richard T. ; Van Besien, Koen ; Izutsu, Koji ; Kersten, Marie Jose ; Magenau, John M. ; Wagner-Johnston, Nina D. ; Kato, Koji ; Corradini, Paolo ; Chu, Jufen ; Gershgorin, Irina ; Choquette, Therese ; Bubuteishvili Pacaud, Lida ; Jeschke, Margit

Blood, 2019-11, Vol.134 (Supplement_1), p.242-242 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL

Barr, Paul M. ; Brown, Jennifer R. ; Hillmen, Peter ; O'Brien, Susan ; Barrientos, Jacqueline C. ; Reddy, Nishitha M. ; Coutre, Steven ; Mulligan, Stephen P. ; Jaeger, Ulrich ; Furman, Richard R. ; Cymbalista, Florence ; Montillo, Marco ; Dearden, Claire ; Robak, Tadeusz ; Moreno, Carol ; Pagel, John M. ; Burger, Jan A. ; Suzuki, Samuel ; Sukbuntherng, Juthamas ; Cole, George ; James, Danelle F. ; Byrd, John C.

Blood, 2017-05, Vol.129 (19), p.2612-2615 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATETM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Barrientos, Jacqueline C. ; O’Brien, Susan ; Brown, Jennifer R. ; Kay, Neil E. ; Reddy, Nishitha M. ; Coutre, Steven ; Tam, Constantine ; Mulligan, Stephen ; Jaeger, Ulrich ; Devereux, Steve ; Pocock, Christopher ; Robak, Tadeusz ; Schuster, Stephen J. ; Schuh, Anna ; Gill, Devinder ; Bloor, Adrian ; Dearden, Claire ; Moreno, Carol ; Cull, Gavin ; Hamblin, Michael ; Jones, Jeffrey A. ; Kierschniak, Tanja ; Eckert, Karl ; Suzuki, Samuel ; Hsu, Emily ; James, Danelle F. ; Byrd, John C. ; Hillmen, Peter

Blood, 2014-12, Vol.124 (21), p.4696-4696 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study
Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study

Bishop, Michael R. ; Dickinson, Michael ; Purtill, Duncan ; Barba, Pere ; Santoro, Armando ; Hamad, Nada ; Kato, Koji ; Sureda, Anna ; Greil, Richard ; Thieblemont, Catherine ; Morschhauser, Franck ; Janz, Martin ; Flinn, Ian W. ; Rabitsch, Werner ; Kwong, Yok Lam ; Kersten, Marie José ; Minnema, Monique C. ; Holte, Harald ; Chan, Esther Hian Li ; Martinez-Lopez, Joaquin ; Mueller, Antonia MS ; Maziarz, Richard T. ; McGuirk, Joseph P. ; Bachy, Emmanuel ; Le Gouill, Steven ; Dreyling, Martin ; Harigae, Hideo ; Bond, David A. ; Andreadis, Charalambos ; McSweeney, Peter A. ; Kharfan-Dabaja, Mohamed A. ; Newsome, Simon ; Degtyarev, Evgeny ; Del Corral, Chris ; Andreola, Giovanna ; Masood, Aisha ; Schuster, Stephen J ; Jaeger, Ulrich ; Borchmann, Peter ; Westin, Jason R.

Blood, 2021-12, Vol.138 (Supplement 2), p.LBA-6-LBA-6 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Boidol, Bernd ; Kornauth, Christoph ; van der Kouwe, Emiel ; Prutsch, Nicole ; Kazianka, Lukas ; Gültekin, Sinan ; Hoermann, Gregor ; Mayerhoefer, Marius E. ; Hopfinger, Georg ; Hauswirth, Alexander ; Panny, Michael ; Aretin, Marie-Bernadette ; Hilgarth, Bernadette ; Sperr, Wolfgang R. ; Valent, Peter ; Simonitsch-Klupp, Ingrid ; Moriggl, Richard ; Merkel, Olaf ; Kenner, Lukas ; Jäger, Ulrich ; Kubicek, Stefan ; Staber, Philipp B.

Blood, 2017-12, Vol.130 (23), p.2499-2503 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia
First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia

Boidol, Bernd ; Kornauth, Christoph ; van der Kouwe, Emiel ; Prutsch, Nicole ; Kazianka, Lukas ; Hoermann, Gregor ; Hopfinger, Georg ; Hauswirth, Alexander ; Aretin, Marie-Bernadette ; Sperr, Wolfgang R. ; Valent, Peter ; Simonitsch-Klupp, Ingrid ; Morrigl, Richard ; Merkel, Olaf ; Kenner, Lukas ; Jaeger, Ulrich ; Kubicek, Stefan ; Staber, Philipp Bernhard

Blood, 2017-12, Vol.130, p.575-575 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUOTM Study
Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUOTM Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUOTM Study

Brown, Jennifer R. ; Flinn, Ian W. ; Davids, Matthew S. ; Hillmen, Peter ; Montillo, Marco ; Nagy, Zsolt ; Delgado, Julio ; Kuss, Bryone J. ; Tam, Constantine S. ; Jaeger, Ulrich ; Ghia, Paolo ; Stilgenbauer, Stephan ; Moreno, Carol ; Le, NgocDiep ; Lustgarten, Stephanie ; Sprott, Kam ; Pachter, Jonathan A. ; Weaver, David T. ; Cymbalista, Florence

Blood, 2018-11, Vol.132 (Supplement 1), p.1856-1856 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.